Bank of America’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31B Sell
46,545,479
-2,235,713
-5% -$59.5M 0.1% 200
2025
Q4
$1.21B Buy
48,781,192
+4,366,553
+10% +$110M 0.09% 217
2025
Q3
$1.13B Sell
44,414,639
-7,045,690
-14% -$174M 0.08% 247
2025
Q2
$1.25B Sell
51,460,329
-4,605,135
-8% -$107M 0.09% 221
2025
Q1
$1.42B Buy
56,065,464
+10,960,392
+24% +$287M 0.11% 174
2024
Q4
$1.2B Sell
45,105,072
-9,257,465
-17% -$251M 0.1% 197
2024
Q3
$1.57B Buy
54,362,537
+1,975,559
+4% +$57.6M 0.13% 165
2024
Q2
$1.47B Sell
52,386,978
-120,785
-0.2% -$3.33M 0.13% 166
2024
Q1
$1.46B Buy
52,507,763
+4,621,652
+10% +$128M 0.13% 162
2023
Q4
$1.38B Sell
47,886,111
-4,308,831
-8% -$130M 0.14% 155
2023
Q3
$1.73B Sell
52,194,942
-7,424,120
-12% -$263M 0.19% 120
2023
Q2
$2.19B Sell
59,619,062
-5,182,137
-8% -$202M 0.23% 94
2023
Q1
$2.64B Buy
64,801,199
+2,341,308
+4% +$101M 0.27% 81
2022
Q4
$3.2B Buy
62,459,891
+1,199,714
+2% +$57.5M 0.36% 56
2022
Q3
$2.68B Sell
61,260,177
-517,033
-0.8% -$25.1M 0.32% 65
2022
Q2
$3.24B Buy
61,777,210
+2,779,143
+5% +$142M 0.37% 53
2022
Q1
$3.05B Buy
58,998,067
+1,549,832
+3% +$80.4M 0.3% 72
2021
Q4
$3.39B Buy
57,448,235
+16,760
+0% +$830K 0.33% 61
2021
Q3
$2.47B Sell
57,431,475
-6,486,515
-10% -$287M 0.25% 83
2021
Q2
$2.5B Sell
63,917,990
-3,933,416
-6% -$153M 0.26% 84
2021
Q1
$2.46B Sell
67,851,406
-639,558
-0.9% -$22.7M 0.28% 79
2020
Q4
$2.52B Sell
68,490,964
-16,712,640
-20% -$613M 0.32% 71
2020
Q3
$2.97B Buy
85,203,604
+2,564,074
+3% +$89.9M 0.4% 56
2020
Q2
$2.56B Sell
82,639,530
-8,708,799
-10% -$296M 0.39% 50
2020
Q1
$2.83B Sell
91,348,329
-12,896,217
-12% -$439M 0.51% 37
2019
Q4
$3.88B Sell
104,244,546
-5,272,143
-5% -$188M 0.56% 30
2019
Q3
$3.73B Buy
109,516,689
+2,497,478
+2% +$90.8M 0.55% 30
2019
Q2
$4.4B Buy
107,019,211
+8,117,279
+8% +$322M 0.67% 20
2019
Q1
$3.99B Sell
98,901,932
-6,141,356
-6% -$246M 0.62% 23
2018
Q4
$4.35B Sell
105,043,288
-4,619,503
-4% -$192M 0.76% 18
2018
Q3
$4.59B Sell
109,662,791
-3,245,529
-3% -$125M 0.71% 21
2018
Q2
$3.89B Buy
112,908,320
+264,877
+0.2% +$9.05M 0.64% 22
2018
Q1
$3.79B Sell
112,643,443
-11,603,723
-9% -$399M 0.65% 21
2017
Q4
$4.27B Sell
124,247,166
-17,303,218
-12% -$590M 0.71% 19
2017
Q3
$4.79B Buy
141,550,384
+14,028,578
+11% +$451M 0.76% 12
2017
Q2
$4.06B Buy
127,521,806
+877,568
+0.7% +$27.7M 0.81% 8
2017
Q1
$4.11B Buy
126,644,238
+2,790,335
+2% +$88M 0.82% 8
2016
Q4
$3.82B Buy
123,853,903
+4,298,874
+4% +$131M 0.83% 8
2016
Q3
$3.84B Buy
119,555,029
+8,391,621
+8% +$281M 0.84% 9
2016
Q2
$3.71B Buy
111,163,408
+1,935,195
+2% +$61.8M 0.86% 7
2016
Q1
$3.07B Buy
109,228,213
+25,218,753
+30% +$720M 0.75% 12
2015
Q4
$2.57B Buy
84,009,460
+2,600,126
+3% +$81.8M 0.61% 20
2015
Q3
$2.43B Buy
81,409,334
+27,271,641
+50% +$874M 0.6% 20
2015
Q2
$1.72B Sell
54,137,693
-234,694
-0.4% -$7.65M 0.56% 22
2015
Q1
$1.79B Buy
54,372,387
+8,857,894
+19% +$282M 0.6% 16
2014
Q4
$1.35B Sell
45,514,493
-10,800,592
-19% -$310M 0.48% 25
2014
Q3
$1.58B Buy
56,315,085
+2,327,488
+4% +$65.3M 0.51% 26
2014
Q2
$1.52B Buy
53,987,597
+2,465,789
+5% +$70.3M 0.49% 33
2014
Q1
$1.57B Sell
51,521,808
-1,514,751
-3% -$45.2M 0.58% 20
2013
Q4
$1.54B Buy
53,036,559
+1,077,373
+2% +$31.4M 0.55% 21
2013
Q3
$1.42B Sell
51,959,186
-27,768,502
-35% -$756M 0.56% 24
2013
Q2
$2.12B Buy
+79,727,688
New +$2.2B 0.89% 7

Other funds holding PFE

Bank of America's PFE Position: Q1 2026 in Review

Bank of America reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $59.5M and leaving 46,545,479 shares worth $1.31B. The position accounts for 0.1% of the portfolio, ranked #200.

Bank of America first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.79B in Q3 2017. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bank of America held 46,545,479 shares of Pfizer worth $1.31B as of Q1 2026.
  • Bank of America sold 2,235,713 Pfizer shares in Q1 2026, an estimated $59.5M.
  • Pfizer made up 0.1% of Bank of America's portfolio in Q1 2026, its #200 holding.
  • Bank of America first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Pfizer position peaked at $4.79B in Q3 2017.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.